Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
1.660
-0.030 (-1.78%)
Oct 15, 2026, 2:19 PM EDT - Market open

Lipocine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
144526153588
Market Cap Growth
-19.02%70.83%75.97%-57.88%-59.76%-2.05%
Enterprise Value
-9306-9152
Last Close Price
1.698.034.882.796.7616.85

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3124.75---
Forward PE
-7.757.757.757.757.75
PS Ratio
8.7522.552.33-5.2070.425.42
PB Ratio
0.643.081.240.730.991.92
P/TBV Ratio
0.633.081.240.730.991.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-14.980.57-2.193.23
EV/EBITDA Ratio
-----16.57
EV/EBIT Ratio
-----16.57

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.03---0.05
Debt / EBITDA Ratio
-----0.73
Net Debt / Equity Ratio
-1.06-1.00-1.03-1.08-0.91-0.97
Net Debt / EBITDA Ratio
1.841.4019.421.232.69-14.09
Net Debt / FCF Ratio
2.061.4816.501.862.6910.03
Asset Turnover
0.070.100.49-0.010.42
Quick Ratio
11.396.3614.448.3919.787.99
Current Ratio
11.486.6814.758.6920.348.26
Return on Equity (ROE)
-60.94%-54.28%0.04%-58.40%-26.50%-2.08%
Return on Assets (ROA)
-37.04%-32.81%-3.17%-37.02%-16.83%5.05%
Return on Invested Capital (ROIC)
----2492.26%-380.64%138.94%
Return on Capital Employed (ROCE)
-57.70%-71.60%-5.50%-88.00%-33.80%6.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-86.34%-21.59%0.03%-110.25%-30.56%-0.73%
FCF Yield
-81.53%-21.89%-5.03%-80.10%-34.37%-5.05%
Buyback Yield / Dilution
-22.05%-0.48%-2.90%-0.26%-1.98%-57.35%
SEC Filings: 10-K · 10-Q